Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

408 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Evaluation of tissue- and plasma-derived tumor mutational burden (TMB) and genomic alterations of interest in CheckMate 848, a study of nivolumab combined with ipilimumab and nivolumab alone in patients with advanced or metastatic solid tumors with high TMB.
He J, Kalinava N, Doshi P, Pavlick DC, Albacker LA, Ebot EM, Tukachinsky H, Pratt J, Fusaro G, Oxnard GR, Green G, Fabrizio D, Baden J. He J, et al. Among authors: doshi p. J Immunother Cancer. 2023 Nov 30;11(11):e007339. doi: 10.1136/jitc-2023-007339. J Immunother Cancer. 2023. PMID: 38035725 Free PMC article. Clinical Trial.
Randomized, open-label, phase 2 study of nivolumab plus ipilimumab or nivolumab monotherapy in patients with advanced or metastatic solid tumors of high tumor mutational burden.
Schenker M, Burotto M, Richardet M, Ciuleanu TE, Gonçalves A, Steeghs N, Schoffski P, Ascierto PA, Maio M, Lugowska I, Lupinacci L, Leary A, Delord JP, Grasselli J, Tan DSP, Friedmann J, Vuky J, Tschaika M, Konduru S, Vemula SV, Slepetis R, Kollia G, Pacius M, Duong Q, Huang N, Doshi P, Baden J, Di Nicola M. Schenker M, et al. Among authors: doshi p. J Immunother Cancer. 2024 Aug 6;12(8):e008872. doi: 10.1136/jitc-2024-008872. J Immunother Cancer. 2024. PMID: 39107131 Free PMC article. Clinical Trial.
FAP-Targeted SPECT/CT and PET/CT Imaging for Breast Cancer Patients.
McGale J, Khurana S, Howell H, Nakhla A, Roa T, Doshi P, Shirini D, Huang A, Duong P, Backhaus P, Liao M, Kaur H, Fontani AM, Hung I, Pandit-Taskar N, Haberkorn U, Gulati A, Naim A, Sinigaglia M, Bebawy M, Girard A, Seban RD, Dercle L. McGale J, et al. Among authors: doshi p. Clin Nucl Med. 2025 Jan 9. doi: 10.1097/RLU.0000000000005617. Online ahead of print. Clin Nucl Med. 2025. PMID: 39780367
The Academic Impact of Society of Interventional Radiology Foundation Grants: Report from the Society of Interventional Radiology Foundation/National Institutes of Health Task Force.
Pal K, Weiss CR, Gade TPF, Glasgow E, Gill K, Palacios V, Doshi P, Oklu R, Woodrum D, Sheth RA. Pal K, et al. Among authors: doshi p. J Vasc Interv Radiol. 2024 Nov 4:S1051-0443(24)00690-0. doi: 10.1016/j.jvir.2024.10.030. Online ahead of print. J Vasc Interv Radiol. 2024. PMID: 39505236
408 results